Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals-Reference-Cited by-同舟云学术

Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals

Published:2014-05 Issue:23 Volume:32 Page:2732-2739
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Frey Sharon E.,Winokur Patricia L.,Hill Heather,Goll Johannes B.,Chaplin Paul,Belshe Robert B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Smallpox and its eradication;Fenner,1988

2. ACAM2000™ Smallpox Vaccine, Vaccines and Related Biological Products Advisory Committee (VRBPAC) Briefing Document; April 18, 2007 [Internet] [cited August 1, 2013], 70p. Available from: http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4292b2-02.pdf.

3. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism;Mayr;Zentralbl Bakteriol,1978

4. MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA);Stickl;Dtsch Med Wochenschr,1974

5. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopox viruses;Antoine;Virology,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial;Vaccine;2024-04

2. MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques;npj Vaccines;2024-02-27

3. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study;Vaccine;2024-01

4. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge;Nature Communications;2023-09-22

5. Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2023-08-24